{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:52:43Z","timestamp":1772034763915,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04736-3","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T07:17:31Z","timestamp":1755674251000},"page":"851-859","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Software mpMR\/US fusion, cognitive, and in-bore biopsy: a comparative analysis of prostate cancer detection"],"prefix":"10.1007","volume":"58","author":[{"given":"Vladislav","family":"Petov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Badyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaliy","family":"Gredzhev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elina","family":"Khalidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Danilov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Ermolaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Redkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaroslav","family":"Chernov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Chinenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timur","family":"Ganzha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Rzayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Timofeeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Fokin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Enikeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Krupinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Aboyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Amosov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"4736_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012663.pub2","volume":"4","author":"FH Drost","year":"2019","unstructured":"Drost FH, Osses DF, Nieboer D, Steyerberg EW, Bangma CH et al (2019) Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev 4:CD012663. https:\/\/doi.org\/10.1002\/14651858.CD012663.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4736_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.vhri.2021.10.007","volume":"30","author":"A Rezapour","year":"2022","unstructured":"Rezapour A, Alipour V, Moradi N, Arabloo J (2022) Cost-effectiveness of multiparametric magnetic resonance imaging and targeted biopsy versus systematic transrectal ultrasound-guided biopsy for prostate cancer diagnosis: a systematic review. Value Health Reg Issues 30:31\u201338. https:\/\/doi.org\/10.1016\/j.vhri.2021.10.007","journal-title":"Value Health Reg Issues"},{"key":"4736_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.urology.2018.04.007","volume":"117","author":"W Liu","year":"2018","unstructured":"Liu W, Patil D, Howard DH, Moore RH, Wang H, Sanda MG et al (2018) Adoption of prebiopsy magnetic resonance imaging for men undergoing prostate biopsy in the United States. Urology 117:57\u201363. https:\/\/doi.org\/10.1016\/j.urology.2018.04.007","journal-title":"Urology"},{"issue":"1","key":"4736_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.euf.2019.03.016","volume":"7","author":"SP Kim","year":"2021","unstructured":"Kim SP, Karnes RJ, Mwangi R, Van Houten H, Gross CP et al (2021) Contemporary trends in magnetic resonance imaging at the time of prostate biopsy: results from a large private insurance database. Eur Urol Focus 7(1):86\u201394. https:\/\/doi.org\/10.1016\/j.euf.2019.03.016","journal-title":"Eur Urol Focus"},{"issue":"2","key":"4736_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41391-024-00896-y","volume":"28","author":"SJC Soerensen","year":"2025","unstructured":"Soerensen SJC, Li S, Langston ME, Fan RE, Rusu M et al (2025) Trends in pre-biopsy MRI usage for prostate cancer detection, 2007\u20132022. Prostate Cancer Prostatic Dis 28(2):519\u2013522. https:\/\/doi.org\/10.1038\/s41391-024-00896-y","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"4736_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20132024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86(2):148\u2013163. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027","journal-title":"Eur Urol"},{"issue":"4","key":"4736_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.eururo.2018.11.040","volume":"75","author":"O Wegelin","year":"2019","unstructured":"Wegelin O, Exterkate L, van der Leest M, Kummer JA, Vreuls W et al (2019) The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies. Eur Urol 75(4):582\u2013590. https:\/\/doi.org\/10.1016\/j.eururo.2018.11.040","journal-title":"Eur Urol"},{"issue":"5","key":"4736_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00345-018-2189-7","volume":"36","author":"S Kaufmann","year":"2018","unstructured":"Kaufmann S, Russo GI, Bamberg F, L\u00f6we L, Morgia G et al (2018) Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy. World J Urol 36(5):761\u2013768. https:\/\/doi.org\/10.1007\/s00345-018-2189-7","journal-title":"World J Urol"},{"issue":"2","key":"4736_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41391-024-00827-x","volume":"28","author":"UG Falagario","year":"2025","unstructured":"Falagario UG, Pellegrino F, Fanelli A, Guzzi F, Bartoletti R et al (2025) Prostate cancer detection and complications of MRI-targeted prostate biopsy using cognitive registration, software-assisted image fusion or in-bore guidance: a systematic review and meta-analysis of comparative studies. Prostate Cancer Prostatic Dis 28(2):270\u2013279. https:\/\/doi.org\/10.1038\/s41391-024-00827-x","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"4736_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41391-021-00449-7","volume":"25","author":"EJ Bass","year":"2022","unstructured":"Bass EJ, Pantovic A, Connor MJ, Loeb S, Rastinehad AR et al (2022) Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 25(2):174\u2013179. https:\/\/doi.org\/10.1038\/s41391-021-00449-7","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"4736_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.eururo.2013.03.030","volume":"64","author":"CM Moore","year":"2013","unstructured":"Moore CM, Kasivisvanathan V, Eggener S, Emberton M, F\u00fctterer JJ et al (2013) Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an international working group. Eur Urol 64(4):544\u2013552. https:\/\/doi.org\/10.1016\/j.eururo.2013.03.030","journal-title":"Eur Urol"},{"issue":"3","key":"4736_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76(3):340\u2013351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033","journal-title":"Eur Urol"},{"issue":"2","key":"4736_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.eururo.2013.10.048","volume":"66","author":"JS Wysock","year":"2014","unstructured":"Wysock JS, Rosenkrantz AB, Huang WC, Stifelman MD, Lepor H et al (2014) A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol 66(2):343\u2013351. https:\/\/doi.org\/10.1016\/j.eururo.2013.10.048","journal-title":"Eur Urol"},{"issue":"10","key":"4736_CR14","doi-asserted-by":"publisher","first-page":"424.e9","DOI":"10.1016\/j.urolonc.2015.06.012","volume":"33","author":"M Valerio","year":"2015","unstructured":"Valerio M, McCartan N, Freeman A, Punwani S, Emberton M, Ahmed HU (2015) Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer. Urol Oncol 33(10):424.e9-424.e16. https:\/\/doi.org\/10.1016\/j.urolonc.2015.06.012","journal-title":"Urol Oncol"},{"issue":"Suppl 3","key":"4736_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/bju.13971","volume":"120","author":"AJ Yaxley","year":"2017","unstructured":"Yaxley AJ, Yaxley JW, Thangasamy IA, Ballard E, Pokorny MR (2017) Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3\u20135 MRI lesions. BJU Int 120(Suppl 3):43\u201350. https:\/\/doi.org\/10.1111\/bju.13971","journal-title":"BJU Int"},{"key":"4736_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.euo.2018.08.022","volume":"2","author":"DN Costa","year":"2019","unstructured":"Costa DN, Goldberg K, Leon AD, Lotan Y, Xi Y, Aziz M, Freifeld Y et al (2019) Magnetic resonance imaging-guided in-bore and magnetic resonance imaging-transrectal ultrasound fusion targeted prostate biopsies: an adjusted comparison of clinically significant prostate cancer detection rate. Eur Urol Oncol 2:397\u2013404. https:\/\/doi.org\/10.1016\/j.euo.2018.08.022","journal-title":"Eur Urol Oncol"},{"key":"4736_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.21037\/tau.2020.02.20","volume":"9","author":"K Zhang","year":"2020","unstructured":"Zhang K, Zhang Z, Liu M, Zhu G, Roobol MJ (2020) Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for na\u00efve biopsy patients. Transl Androl Urol 9:243\u2013249. https:\/\/doi.org\/10.21037\/tau.2020.02.20","journal-title":"Transl Androl Urol"},{"key":"4736_CR18","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/JU.0000000000001476","volume":"205","author":"CC Khoo","year":"2021","unstructured":"Khoo CC, Eldred-Evans D, Peters M, van Son M, van Rossum PSN, Connor MJ et al (2021) A comparison of prostate cancer detection between visual estimation (cognitive registration) and image fusion (software registration) targeted transperineal prostate biopsy. J Urol 205:1075\u20131081. https:\/\/doi.org\/10.1097\/JU.0000000000001476","journal-title":"J Urol"},{"key":"4736_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133443","volume":"15","author":"GM Pirola","year":"2023","unstructured":"Pirola GM, Castellani D, Orecchia L, Giulioni C, Gubbiotti M, Rubilotta E et al (2023) Transperineal US-MRI fusion-guided biopsy for the detection of clinical significant prostate cancer: a systematic review and meta-analysis comparing cognitive and software-assisted technique. Cancers (Basel) 15:3443. https:\/\/doi.org\/10.3390\/cancers15133443","journal-title":"Cancers (Basel)"},{"key":"4736_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/iju.14127","volume":"27","author":"Y Yamada","year":"2020","unstructured":"Yamada Y, Shiraishi T, Ueno A, Ueda T, Fujihara A, Naitoh Y et al (2020) Magnetic resonance imaging-guided targeted prostate biopsy: comparison between computer-software-based fusion versus cognitive fusion technique in biopsy-na\u00efve patients. Int J Urol 27:67\u201371. https:\/\/doi.org\/10.1111\/iju.14127","journal-title":"Int J Urol"},{"key":"4736_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.eururo.2018.08.007","volume":"75","author":"S Hamid","year":"2019","unstructured":"Hamid S, Donaldson IA, Hu Y, Rodell R, Villarini B, Bonmati E et al (2019) The SmartTarget biopsy trial: a prospective, within-person randomised, blinded trial comparing the accuracy of visual-registration and magnetic resonance imaging\/ultrasound image-fusion targeted biopsies for prostate cancer risk stratification. Eur Urol 75:733\u2013740. https:\/\/doi.org\/10.1016\/j.eururo.2018.08.007","journal-title":"Eur Urol"},{"key":"4736_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.purol.2017.10.001","volume":"28","author":"S Albisinni","year":"2018","unstructured":"Albisinni S, Aoun F, Noel A, El Rassy E, Lemort M, Paesmans M et al (2018) Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies? Prog Urol 28:18\u201324. https:\/\/doi.org\/10.1016\/j.purol.2017.10.001","journal-title":"Prog Urol"},{"key":"4736_CR23","doi-asserted-by":"publisher","first-page":"7544","DOI":"10.1007\/s00330-022-08822-3","volume":"32","author":"D Deniffel","year":"2022","unstructured":"Deniffel D, Perlis N, Ghai S, Girgis S, Healy GM, Fleshner N et al (2022) Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy. Eur Radiol 32:7544\u20137554. https:\/\/doi.org\/10.1007\/s00330-022-08822-3","journal-title":"Eur Radiol"},{"key":"4736_CR24","doi-asserted-by":"publisher","first-page":"11183","DOI":"10.12998\/wjcc.v9.i36.11183","volume":"9","author":"C Pang","year":"2021","unstructured":"Pang C, Wang M, Hou HM, Liu JY, Zhang ZP, Wang X et al (2021) Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer. World J Clin Cases 9:11183\u201311192. https:\/\/doi.org\/10.12998\/wjcc.v9.i36.11183","journal-title":"World J Clin Cases"},{"key":"4736_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175612","volume":"12","author":"W Malewski","year":"2023","unstructured":"Malewski W, Milecki T, Szempli\u0144ski S, Tayara O, Kuncman \u0141 et al (2023) Prostate biopsy in the case of PIRADS 5 \u2013 is systematic biopsy mandatory? J Clin Med 12:5612. https:\/\/doi.org\/10.3390\/jcm12175612","journal-title":"J Clin Med"},{"key":"4736_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/JU.0000000000001766","volume":"206","author":"A Tafuri","year":"2021","unstructured":"Tafuri A, Iwata A, Shakir A, Iwata T, Gupta C et al (2021) Systematic biopsy of the prostate can be omitted in men with PI-RADS\u2122 5 and prostate specific antigen density greater than 15. J Urol 206:289\u2013297. https:\/\/doi.org\/10.1097\/JU.0000000000001766","journal-title":"J Urol"},{"key":"4736_CR27","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.4081\/aiua.2024.12992","volume":"96","author":"P Pepe","year":"2024","unstructured":"Pepe P, Pepe L, Fiorentino V, Curduman M, Fraggetta F (2024) Multiparametric MRI targeted prostate biopsy: When omit systematic biopsy? Arch Ital Urol Androl 96:12992. https:\/\/doi.org\/10.4081\/aiua.2024.12992","journal-title":"Arch Ital Urol Androl"},{"key":"4736_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12894-017-0310-7","volume":"17","author":"Y Hakozaki","year":"2017","unstructured":"Hakozaki Y, Matsushima H, Kumagai J, Murata T, Masuda T et al (2017) A prospective study of magnetic resonance imaging and ultrasonography (MRI\/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer. BMC Urol 17:117. https:\/\/doi.org\/10.1186\/s12894-017-0310-7","journal-title":"BMC Urol"},{"key":"4736_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41391-021-00485-3","volume":"25","author":"AYM Lee","year":"2022","unstructured":"Lee AYM, Chen K, Tan YG, Lee HJ, Shutchaidat V et al (2022) Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy\u2014implications on clinically-significant prostate cancer detection and relevance to focal therapy planning. Prostate Cancer Prostatic Dis 25:720\u2013726. https:\/\/doi.org\/10.1038\/s41391-021-00485-3","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4736_CR30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.eururo.2015.06.008","volume":"68","author":"C Arsov","year":"2015","unstructured":"Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A et al (2015) Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol 68:713\u2013720. https:\/\/doi.org\/10.1016\/j.eururo.2015.06.008","journal-title":"Eur Urol"},{"key":"4736_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamasurg.2019.1734","volume":"154","author":"FF Elkhoury","year":"2019","unstructured":"Elkhoury FF, Felker ER, Kwan L, Sisk AE, Delfin M et al (2019) Comparison of targeted vs systematic prostate biopsy in men who are biopsy naive: the prospective assessment of image registration in the diagnosis of prostate cancer (PAIREDCAP) study. JAMA Surg 154:811\u2013818. https:\/\/doi.org\/10.1001\/jamasurg.2019.1734","journal-title":"JAMA Surg"},{"key":"4736_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156040","volume":"271","author":"V Fiorentino","year":"2025","unstructured":"Fiorentino V, Pepe L, Zuccal\u00e0 V, Pizzimenti C, Ieni A et al (2025) Gleason score down and upgrading at radical prostatectomy in targeted vs. systematic prostate biopsy: findings from an institutional cohort. Pathol Res Pract 271:156040. https:\/\/doi.org\/10.1016\/j.prp.2025.156040","journal-title":"Pathol Res Pract"},{"key":"4736_CR33","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/cncr.29874","volume":"122","author":"CP Filson","year":"2016","unstructured":"Filson CP, Natarajan S, Margolis DJ, Huang J, Lieu P et al (2016) Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies. Cancer 122:884\u2013892. https:\/\/doi.org\/10.1002\/cncr.29874","journal-title":"Cancer"},{"issue":"6","key":"4736_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.clgc.2023.06.007","volume":"21","author":"P Pepe","year":"2023","unstructured":"Pepe P, Pennisi M (2023) Targeted biopsy in men high risk for prostate cancer: 68Ga-PSMA PET\/CT versus mpMRI. Clin Genitourin Cancer 21(6):639\u2013642. https:\/\/doi.org\/10.1016\/j.clgc.2023.06.007","journal-title":"Clin Genitourin Cancer"},{"issue":"19","key":"4736_CR35","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1001\/jama.2025.3579","volume":"333","author":"A Kinnaird","year":"2025","unstructured":"Kinnaird A, Luger F, Cash H, Ghai S, Urdaneta-Salegui LF et al (2025) Microultrasonography-guided vs MRI-guided biopsy for prostate cancer diagnosis: the OPTIMUM randomized clinical trial. JAMA 333(19):1679\u20131687. https:\/\/doi.org\/10.1001\/jama.2025.3579","journal-title":"JAMA"},{"issue":"5","key":"4736_CR36","doi-asserted-by":"publisher","first-page":"e860","DOI":"10.1016\/j.clgc.2019.05.006","volume":"17","author":"X Tu","year":"2019","unstructured":"Tu X, Liu Z, Chang T, Qiu S, Xu H et al (2019) Transperineal magnetic resonance imaging\u2013targeted biopsy may perform better than transrectal route in the detection of clinically significant prostate cancer: systematic review and meta-analysis. Clin Genitourin Cancer 17(5):e860\u2013e870. https:\/\/doi.org\/10.1016\/j.clgc.2019.05.006","journal-title":"Clin Genitourin Cancer"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04736-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04736-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04736-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:30:48Z","timestamp":1772029848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04736-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4736"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04736-3","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}